Plain-English translation of NCT07098026 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing whether a traditional herbal medicine called can help prevent advanced stomach cancer from returning after surgery. You would take the medication (or a placebo) alongside standard chemotherapy before and after your surgery. Researchers want to understand if this combination treatment is safe and effective at reducing the risk of cancer recurrence.
Advanced stomach cancer has a high risk of coming back after surgery, and doctors are looking for additional treatments that might improve outcomes and reduce this risk when combined with standard chemotherapy.
You likely qualify if…
You likely don't qualify if…
You will receive chemotherapy as planned, and take either the herbal medication or a placebo daily in sync with your chemotherapy. You will have visits every 3 weeks for blood tests and check-ups, and researchers will monitor you for any side effects and track whether your cancer returns. The treatment continues until your cancer progresses, you experience unacceptable side effects, or the study ends.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
China